TOMI Environmental Solutions Inc. announced that a leading Cell and Gene Therapy (CGT) manufacturer has adopted its SteraMist ionized Hydrogen Peroxide (iHP) technology at a new commercial-scale pharmaceutical manufacturing facility. The implementation includes multiple SteraMist systems for surface treatment and automated room fogging, as well as TOMI’s standard operating procedure development package and an Installation and Operational Qualification package. The company’s iHP Corporate Service team will also perform comprehensive whole-facility fogging services for the client.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TOMI Environmental Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9616204) on December 22, 2025, and is solely responsible for the information contained therein.